Significant association between hypolipoproteinemia(a) and lifetime risk of cancer: an autopsy study from a community-based Geriatric Hospital.

[1]  K. Kayaba,et al.  Low Lipoprotein(a) Concentration Is Associated with Cancer and All-Cause Deaths: A Population-Based Cohort Study (The JMS Cohort Study) , 2012, PloS one.

[2]  J. Borén,et al.  Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.

[3]  D. Gerber,et al.  Paraneoplastic syndromes: an approach to diagnosis and treatment. , 2010, Mayo Clinic proceedings.

[4]  M. Naka,et al.  High lipoprotein(a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases , 2009, Heart.

[5]  Hui Zhao,et al.  A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c‐Src phosphorylation in VEGF‐induced human umbilical endothelial cells , 2009, International journal of cancer.

[6]  Wei Hu,et al.  Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer , 2009, Clinical chemistry and laboratory medicine.

[7]  G. Lippi,et al.  Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. , 2007, Cancer treatment reviews.

[8]  S. Pizzo,et al.  Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated , 2005, Journal of cellular biochemistry.

[9]  S. Hong,et al.  Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) Kringles , 2004, Cancer Research.

[10]  N. Malliaraki,et al.  Hypercoagulable States in Patients with Hepatocellular Carcinoma , 2003, Digestive Diseases and Sciences.

[11]  K. Jung,et al.  Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a)* , 2003, Journal of Biological Chemistry.

[12]  M. Malaguarnera,et al.  Lipoprotein (a) behaviour in patients with hepatocellular carcinoma. , 2001, Minerva medica.

[13]  V. Trieu,et al.  Apolipoprotein(a), a link between atherosclerosis and tumor angiogenesis. , 1999, Biochemical and biophysical research communications.

[14]  R. Barr,et al.  Blood lipid profiles in children with acute lymphoblastic leukemia , 1998, Cancer.

[15]  S. Ferretti,et al.  Effects of androgen suppression by gonadotropin-releasing hormone agonist and flutamide on lipid metabolism in men with prostate cancer: focus on lipoprotein(a). , 1996, Clinical chemistry.

[16]  E. Peuchant,et al.  Lipoprotein(a) in 505 hospitalized patients with various pathological states: correlations with cardiovascular diseases and therapies. , 1996, International angiology : a journal of the International Union of Angiology.

[17]  J. W. Wersch.  The behaviour of Lipoprotein(a) in patients with various diseases , 1994 .

[18]  H. Baloglu,et al.  Elevated serum Lp(a) levels in the early and advanced stages of breast cancer. , 1994, Cancer biochemistry biophysics.

[19]  M. Seishima,et al.  Lp(a): an acute-phase reactant? , 1994, Chemistry and physics of lipids.

[20]  A. Kuesel,et al.  Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease , 1992, International journal of cancer.

[21]  P. Burtin,et al.  A comparative study of the localization of plasminogen and apolipoprotein(a) in human carcinomas. , 1990, Thrombosis research.

[22]  C. Mountford,et al.  Elevated apolipoprotein(A) levels in cancer patients , 1989, International journal of cancer.